image
NeuroBo Pharmaceuticals, Inc. NRBO
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 2.22
-8.64 %
$ 19.1 M
Market Cap
-0.55
P/E
INCOME STATEMENT
0 REVENUE
0.00%
Growth Rates
1Year 0.00%
3Years 0.00%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-15.9 M OPERATING INCOME
19.06%
Growth Rates
1Year 19.06%
3Years 18.84%
5Years 6.98%
7Years -1.12%
10Years 0.00%
-12.5 M NET INCOME
10.72%
Growth Rates
1Year 10.72%
3Years 25.10%
5Years 12.01%
7Years 2.21%
10Years 0.00%
EFFICIENCY
Earnings Waterfall NeuroBo Pharmaceuticals, Inc.
image
Revenue 0
Cost Of Revenue 0
Gross Profit 0
Operating Expenses 15.9 M
Operating Income -15.9 M
Other Expenses -3.42 M
Net Income -12.5 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014
REVENUE
Revenue 0 0 0 0 0 0 0 0 0 0
GROSS PROFIT
Cost Of Revenue 0 28 K 72 K 67 K 17 K 0 0 0 0 0
Gross Profit 0 28 K 72 K 67 K 17 K 0 0 0 0 0
OPERATING INCOME
Operating Expenses 15.9 11.4 15.3 29.7 20.2 22.8 33.1 14.7 7.2 0.3
Selling, General and Administrative Expenses 6.7 8.6 8.8 7.8 2.7 8.5 10.4 6.0 3.2 0.2
Research and Development Expenses 9.2 2.8 6.5 21.9 17.5 14.3 22.7 8.7 4.0 52 K
Operating Income (15.9) (19.6) (15.3) (29.7) (20.2) (22.8) (33.1) (14.7) (8.1) (0.3)
PRE-TAX INCOME
Interest Income Expense 0 2.2 0 39 K 22 K 0.7 0 0 0 0
Total Other Income 3.4 5.7 14 K 38 K (1.1) 43 K (0.3) 0.1 (1.0) 54 K
Pre-Tax Income (12.5) (14.0) (15.3) (29.7) (21.3) (23.6) (33.4) (14.6) (9.0) (0.3)
NET INCOME
Tax Provision 0 (7.9) 62 K 85 K 1.1 0.7 0.3 (0.1) (0.1) 55 K
Net Income (12.5) (6.1) (15.2) (29.6) (22.4) (23.6) (33.4) (14.6) (9.0) (0.3)
EPS 2.46 19 158 438 1.03 K 167 2.42 K 1.88 K 1.28 K 45.3